Previous studies have reported that PDCD6 promotes breast cancer growth and metastasis by regulating the cytoskeleton and mediating the proapoptotic activity of cisplatin and TNF-α through the downregulation of NF-κB expression in different biological process [22, 40]. This evidence concerns the gene NFKB1 and breast carcinoma.